The study “GP awareness about chemoprevention” was carried out on behalf of Cancer Research UK, and aimed to specifically explore GP awareness on tamoxifen and aspirin use with breast and bowel cancers.
The survey took place in May 2016 in the UK and involved over 1,000 physicians from our panel. You can access the study here and see a summary together with the main findings below.
How to make extra money during the holiday season as a physician? Participating in paid healthcare market research studies with M3 offers a flexible and lucrative opportunity, especially for physicians.
Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.
Real-World Evidence studies collect real-world data to evaluate the safety and performance of medical devices. This M3 Guide reveals how we conduct Real-World Evidence studies, how they contribute to better patient outcomes, and how healthcare professionals can get compensated.
